抗菌药物耐药负担研究测算方法现状与分析(6)
[23] CHARLSON ME，POMPEI P，ALES KL，et al. A new method of classifying prognostic comorbidity in longitudinal studies：development and validation[J]. J Chronic Dis，1987，40(5)：373-383.
[24] KNAUS WA，DRAPER EA，WAGNER DP，et al. APACHE Ⅱ：a severity of disease classification system[J]. Crit Care Med，1985，13(10)：818-829.
[25] ROBINS JM. The control of confounding by intermediate variables[J]. Stat Med，1989，8(6)：679-701.
[26] PERENCEVICH EN. Excess shock and mortality in Sta- phylococcus aureus related to methicillin resistance[J]. Clin Infect Dis，2000，31(5)：1311-1313.
[27] BJORKMAN J，ANDERSSON DI. The cost of antibiotic resistance from a bacterial perspective[J]. Drug Resist Updat，2000，3(4)：237-245.
[28] BJ?RKMAN J，NAGAEV I，BERG OG，et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance[J]. Science，2000，287(5457)：1479-1482.
[29] HOWARD D，CORDELL R，MCGOWAN JE JR，et al. Measuring the economic costs of antimicrobial resistance in hospital settings：summary of the Centers for Disease Control and Prevention-Emory Workshop[J]. Clin Infect Dis，2001，33(9)：1573-1578.
[30] 曾鈺，余野，邱峰，等.抗菌药物专项整治前后重庆地区34家医院抗菌药物销售情况分析[J].中国药房，2015，26(14)：1910-1913.
(收稿日期：2017-08-28 修回日期：2017-12-21)
(编辑：刘明伟), 百拇医药(海沙尔江·吾守尔 魏国旭 管晓东 史录文)
[24] KNAUS WA，DRAPER EA，WAGNER DP，et al. APACHE Ⅱ：a severity of disease classification system[J]. Crit Care Med，1985，13(10)：818-829.
[25] ROBINS JM. The control of confounding by intermediate variables[J]. Stat Med，1989，8(6)：679-701.
[26] PERENCEVICH EN. Excess shock and mortality in Sta- phylococcus aureus related to methicillin resistance[J]. Clin Infect Dis，2000，31(5)：1311-1313.
[27] BJORKMAN J，ANDERSSON DI. The cost of antibiotic resistance from a bacterial perspective[J]. Drug Resist Updat，2000，3(4)：237-245.
[28] BJ?RKMAN J，NAGAEV I，BERG OG，et al. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance[J]. Science，2000，287(5457)：1479-1482.
[29] HOWARD D，CORDELL R，MCGOWAN JE JR，et al. Measuring the economic costs of antimicrobial resistance in hospital settings：summary of the Centers for Disease Control and Prevention-Emory Workshop[J]. Clin Infect Dis，2001，33(9)：1573-1578.
[30] 曾鈺，余野，邱峰，等.抗菌药物专项整治前后重庆地区34家医院抗菌药物销售情况分析[J].中国药房，2015，26(14)：1910-1913.
(收稿日期：2017-08-28 修回日期：2017-12-21)
(编辑：刘明伟), 百拇医药(海沙尔江·吾守尔 魏国旭 管晓东 史录文)